Danish pharmaceutical giant Novo Nordisk on Tuesday announced the launch of its anti-obesity drug Wegovy in India, targeting ...

Novo Nordisk is making a strategic move into one of the world's fastest-growing obesity markets by launching its blockbuster ...

Danish drugmaker Novo Nordisk has fast-tracked the India launch of its blockbuster anti-obesity drug Wegovy (semaglutide 2.4 ...

The drug works by acting on key areas of the brain involved in appetite regulation and food intake thereby reducing hunger, ...

Novo Nordisk launches Wegovy in India, a once-weekly weight-loss injection shown to aid obesity treatment and reduce heart ...

Novo Nordisk decodes India’s obesity drug market with Wegovy positioned as once-a-week novel weight management medication: ...

According to a study in The Lancet, over 14.4 million children in India are obese, making the country home to the ...

A new study analyzing NFHS-5 data reveals India’s most obese state. With alarming obesity rates across cities, experts warn ...

Obesity in India is a chronic disease, not a personal failure, requiring empathy, science-based treatment, and public health ...

Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...

There has been a sharp rise in cases of fibroids among young Indian women across India in recent years, according to experts. Fibroids are non-cancerous growths in the uterus and are being diagnosed ...